Status:
COMPLETED
Observational Study on the Patients With Rectal Cancer
Lead Sponsor:
Chinese Academy of Medical Sciences
Conditions:
Rectal Cancer
Adjuvant Chemoradiotherapy
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this observational study is to retrospectively collect current survival data for 3995 primary rectal cancer patients who were extracted from 5097 rectal cancer patients admitted in Cancer H...
Eligibility Criteria
Inclusion
- Aged older than 18 years
- American Joint Committee on Cancer (six edition) stage I through IV disease
- Received either transabdominal resection, transanal excision, preoperative radiotherapy or chemoradiotherapy
- Had the histologic subtypes adenocarcinoma (not otherwise specified, mucinous or mucin-producing, mixed cell or with mixed subtypes, tubular, and papillary)
Exclusion
- Had the histologic subtypes squamous cell carcinoma, carcinoid, neuroendocrine tumor, small cell carcinoma, leiomyosarcoma, sarcoma, gastrointestinal stromal sarcoma, melanoma, carcinosarcoma, rhabdoid tumors, or malignant peripheral nerve sheet tumors
- Only receive palliative surgery such as colostomy, sigmoidostomy
- Received palliative radiotherapy or chemoradiotherapy for metastatic disease
- With unresectable distant metastasis in liver, lung, bone, central nervous system , or peritoneal transplantation
- Had no detailed medical records
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
3995 Patients enrolled
Trial Details
Trial ID
NCT02312284
Start Date
January 1 2011
End Date
November 1 2014
Last Update
January 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Beijing, China, 100021